When should low-dose aspirin (acetylsalicylic acid) be started for preeclampsia prevention during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Start Low-Dose Aspirin for Preeclampsia Prevention During Pregnancy

Low-dose aspirin (81 mg/day) should be initiated between 12-16 weeks of gestation and continued until delivery in women at high risk for preeclampsia. 1, 2, 3

Risk Assessment for Preeclampsia

High-Risk Factors (any one of these warrants aspirin prophylaxis):

  • History of preeclampsia, especially early-onset preeclampsia with delivery <34 weeks 4, 1
  • Multifetal gestation 1, 2
  • Chronic hypertension 1, 2
  • Type 1 or type 2 diabetes 1, 2
  • Renal disease 1, 2
  • Autoimmune disease (such as systemic lupus erythematosus or antiphospholipid syndrome) 1, 2

Moderate-Risk Factors (consider aspirin if more than one present):

  • First pregnancy (nulliparity) 4, 2
  • Maternal age ≥35 years 4, 2
  • BMI >30 kg/m² 4, 2
  • Family history of preeclampsia (mother or sister) 4, 2
  • Sociodemographic characteristics (low socioeconomic status) 2, 3

Dosage Recommendations

  • Standard dose: 81 mg/day for most high-risk women 4, 2
  • For women with diabetes: Consider higher dose (100-150 mg/day) 1, 5
  • For women with higher BMI (>40 kg/m²): May require dose adjustment 1

Timing of Initiation

  • Optimal timing: Between 12-16 weeks of gestation 4, 2
  • Acceptable range: Between 12-28 weeks of gestation 4, 3
  • Never before 12 weeks (no trials have evaluated earlier initiation) 4
  • Evidence does not show additional benefit of starting before 16 weeks compared to after 16 weeks 4

Duration of Treatment

  • Continue daily until delivery 1, 2
  • No evidence supports discontinuation before delivery 2, 3

Special Considerations

Effectiveness

  • Number needed to treat to prevent one case of preeclampsia: 42 4
  • Number needed to treat to prevent one case of intrauterine growth restriction: 71 4
  • Number needed to treat to prevent one case of preterm birth: 65 4

Safety Profile

  • Low-dose aspirin has not been shown to increase risk of:
    • Placental abruption 4
    • Postpartum hemorrhage 4
    • Maternal bleeding 4
    • Intracranial hemorrhage in neonates 4
    • Perinatal mortality 4

Emerging Evidence and Controversies

  • Some recent evidence suggests that doses >100 mg may be more effective than the standard 81 mg dose, particularly for women with diabetes or higher BMI 1, 5
  • The International Federation of Gynecology and Obstetrics recommends 150 mg of aspirin (or 2 tablets of 81 mg as an acceptable alternative) 5
  • Some researchers have proposed starting aspirin earlier than 12 weeks, but this approach lacks sufficient evidence from clinical trials 6
  • Evening or bedtime administration may provide better outcomes than morning dosing 7

Common Pitfalls to Avoid

  • Delaying initiation beyond 16 weeks in high-risk women 2, 3
  • Failing to identify high-risk women who would benefit from prophylaxis 4, 2
  • Discontinuing aspirin before delivery 2, 3
  • Using prophylactic aspirin in low-risk women without risk factors 2, 3
  • Not adjusting dosage for women with diabetes or high BMI 1, 5

References

Guideline

Aspirin Prophylaxis in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.